BioMarin Pharmaceutical Inc.

Q2 2024 13F Holders

Symbol
BMRN
CUSIP
09061G101
Type
Equity
Class
COM
Num filers
566
Total reported value, excl. options
$15.2B
Manager Report Date Value ($000) Shares